a Neo-adjuvant Chemotherapy Immunotherapy in Resectable ESCC Study

Clinical trial NCT06472635 · UNKNOWN

Trial details

NCT number: NCT06472635
Sponsor: Zhejiang University
Status: UNKNOWN
Study type: OBSERVATIONAL

The Neoadjuvant Treatment for Resectable Esophageal Squamous Cell Carcinoma

Start date: 2022-03-01
Primary completion: 2024-09-30
Enrollment: 95

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.